Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.

The Korean journal of parasitology

Volumn 44, Issue 1, 2006, Pages 55-61

  Solgi, Ghassem ^a   Kariminia, Amina ^a   Abdi, Khossor ^a   Darabi, Majid ^a   Ghareghozloo, Behnaz ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND; THALIDOMIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; FEMALE; IMMUNOLOGY; LEISHMANIA MAJOR; MOUSE; TIME; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, VISCERAL; MEGLUMINE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; THALIDOMIDE; TIME FACTORS;

EID: 33646852822     PISSN: 00234001     EISSN: None     Source Type: Journal    
DOI: 10.3347/kjp.2006.44.1.55     Document Type: Article

References (0)